Goldman Sachs Downgrades GE HealthCare Techs to Neutral, Lowers Price Target to $65

Benzinga Newsdesk www.benzinga.com Negative 92.0%

Neg 92% Neu 0% Pos 0%

Goldman Sachs analyst David Roman downgrades GE HealthCare Techs (NASDAQ:GEHC) from Buy to Neutral and lowers the price target from $81 to $65.